TABLE 3.
Survival (in days) of groups of 10 mice infected with 7.3 × 105 CFU of C. albicans per mouse and treated from day 1 through 10 with amphotericin B or KY-62a
Group | Mean | SEM |
---|---|---|
Control | 7.4 | 1.5 |
Amphotericin B, 1 mg/kg i.v. | 28.1b | 2.9 |
Amphotericin B, 5 mg/kg i.p. | 31b | 0.0 |
KY-62, 1 mg/kg i.p. | 28.7b | 1.6 |
KY-62, 5 mg/kg i.p. | 28.3b | 2.7 |
KY-62, 10 mg/kg i.p. | 31b | 0.0 |
KY-62, 20 mg/kg i.p. | 31b | 0.0 |
KY-62, 30 mg/kg i.p. | 31b | 0.0 |
Observation was continued through day 30 after infection.
Significant prolongation of survival compared with controls.